UK Markets closed

Coloplast A/S - Transactions in connection with share buy-back programme, week 16 (programme completed)

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Coloplast A/S
Coloplast A/S

As mentioned in Announcement no. 03/2022 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.
The programme commenced on 21 February 2022 and will end no later than 19 August 2022.

The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.

The following transactions have been executed during the period 18 - 22 April 2022:


Number of shares

Average purchase price, DKK

Transaction value, DKK

18 April 2022




19 April 2022




20 April 2022




21 April 2022




22 April 2022




Accumulated until now under the programme




Henceforth, Coloplast owns 3,692,876 treasury B shares of DKK 1 equal to 1,71% of the company’s total share capital.

An overview showing the transaction data for the period 18 – 22 April 2022 is enclosed.

Coloplast’s share buyback programme initiated on 21 February 2022, and as described in Announcement 03/2022, is hereby completed.

Kind regards
Investor Relations
Coloplast A/S
Tel. +45 4911 1800

For further information, please contact

Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 /+45 4911 3376

Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458

Press and the media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623

Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Company reg. (CVR) no. 69749917


This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound & Skin Care, Interventional Urology and Voice & Respiratory Care. We operate globally and employ about 14,000 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-04.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting